Latest Headlines

1. Volta Labs Expands Presence In The Nordic Region With Callisto Placement At Norway's Norwegian Sequencing Centre, University Of Oslo 7/3/2025

   Volta Labs, Inc., a leading genomics applications company, announced today the expansion of its commercial presence in Europe with the installation of its Callisto Sample Prep System™ at the Norwegian Sequencing Centre (NSC) in Oslo, Norway.

2. Spartanburg Regional Healthcare System (SRHS) Selects AccessDx Laboratory As Pharmacogenomics (PGx) Program Partner 7/2/2025

   Spartanburg Regional Healthcare System (SRHS) has selected AccessDx Laboratory as its partner to power a comprehensive pharmacogenomics (PGx) program.

3. Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver 7/2/2025

   Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.

4. VIAVI Introduces Colocation Capability At VALOR Lab-As-A-Service Testing Facility 7/2/2025

   VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced that it has added colocation capability to its VIAVI Automated Lab-as-a-Service for Open RAN (VALOR™) facility to address the increased demand for comprehensive testing from Open RAN customers.

5. Adaptive Biotechnologies And Flatiron Health Announce Integration Of clonoSEQ®: MRD Testing Into OncoEMR® 7/1/2025
6. Seegene Launches STAgora™, A New Platform For Infectious Disease Analytics 7/1/2025

   Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics.

7. Diatron Launches P780, The Most Advanced Clinical Chemistry System! 7/1/2025

   Diatron—a trusted partner in developing, manufacturing and marketing hematology and clinical chemistry analyzers and associated reagents for human medical and veterinary use—has launched its new clinical chemistry analyzer, the P780.

8. PathAI Receives FDA Clearance For AISight® Dx Platform For Primary Diagnosis 6/30/2025

   PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight® Dx*—its digital pathology image management system—for use in primary diagnosis in clinical settings.

9. RetinalGenix Technologies Contracts With LabCorp To Support DNA/GPS Platform For Advanced Genetic And Retinal Health Screening 6/27/2025

   RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic screening, monitoring, pharmacogenetic mapping, and repurposed drug development for early detection and treatment of eye and systemic diseases, has entered into an agreement with LabCorp, one of the nation’s largest laboratory services organizations, to support the rollout of the RetinalGenix DNA/RNA/GPS Pharmaco-Genetic Mapping™ platform.

10. STEMCELL Technologies Introduces STEMprep Tissue Dissociator System To Accelerate Research Discoveries 6/27/2025

    To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes.